Launch event
Whether you’re looking for immediate efficiencies or an ongoing clinical edge, Symbia Pro.specta™ with myExam Companion is your way forward.
Register here to watch the recorded launch event.
Moving SPECT/CT forward
Modernize to MAXIMIZE
2004
Scroll through the galleries to recollect on Symbia SPECT/CT's journey since 2004, and see where we go from here.
2006
2008
2013
2016
2017
2020
2022
Launch of Symbia Pro.specta SPECT/CT.
1
The statements by Siemens Healthineers’ customers described herein are based on results that were achieved in the customer’s unique setting. Since there is no “typical” hospital and many variables exist (e.g., hospital size, case mix, level of IT adoption) there can be no guarantee that other customers will achieve the same results. 2
In clinical practice, the use of SAFIRE may reduce CT patient dose depending on the clinical task, patient size, anatomical location, and clinical practice. A consultation with a radiologist and physicist should be made to determine the appropriate dose to obtain diagnostic image quality for the particular clinical task.3
The amount of metal artifact reduction and corresponding improvement in image quality depends on a number of factors including composition and size of the metal object, patient size, anatomical location, and clinical practice. It is recommended to perform reconstructions with iMAR enabled in addition to conventional reconstruction without iMAR.4
xSPECT Quant 131I is not commercially available in all countries. Due to regulatory reasons, its future availability cannot be guaranteed. Please contact your local Siemens Healthineers organization for further details.
Symbia Pro.specta and its features are not commercially available in all countries. Due to regulatory reasons, their future availability cannot be guaranteed. Please contact your local Siemens Healthineers organization for further details.